FENNEC PHARMACEUTICALS INC. (FENC) Profit Margins
Over the twelve months to 2026-06-30, FENNEC PHARMACEUTICALS INC. (FENC) had operating margin -1.9%, net margin -5.5%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
FENCFENNEC PHARMACEUTICALS INC.Follow FENC — free
—
Price chart with a free account
- Market cap
- 353.5M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2020 Dec 20 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Gross margin | — | 94.4% | 94.1% | — | — | — | |
| Operating margin | -10520.6% | -1471.6% | -60.1% | 5.4% | -14.1% | -1.9% | |
| Net margin | -10652.4% | -1544.9% | -75.5% | -0.9% | -21.8% | -5.5% |
USD millions · SEC XBRL
FENNEC PHARMACEUTICALS INC. — questions
- What is FENNEC PHARMACEUTICALS INC.'s operating margin?
- -1.9% over the twelve months to 2026-06-30.
- What is FENNEC PHARMACEUTICALS INC.'s net profit margin?
- -5.5% over the twelve months to 2026-06-30.
Every figure on this page comes from FENNEC PHARMACEUTICALS INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.